Cargando…
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286545/ https://www.ncbi.nlm.nih.gov/pubmed/34358943 http://dx.doi.org/10.1016/j.msard.2021.103155 |
| _version_ | 1783723736589926400 |
|---|---|
| author | Giovannoni, Gavin Hawkes, Christopher H. Lechner-Scott, Jeannette Levy, Michael Yeh, E. Ann Baker, David |
| author_facet | Giovannoni, Gavin Hawkes, Christopher H. Lechner-Scott, Jeannette Levy, Michael Yeh, E. Ann Baker, David |
| author_sort | Giovannoni, Gavin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8286545 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82865452021-07-20 COVID-19 vaccines and multiple sclerosis disease-modifying therapies Giovannoni, Gavin Hawkes, Christopher H. Lechner-Scott, Jeannette Levy, Michael Yeh, E. Ann Baker, David Mult Scler Relat Disord Editorial Published by Elsevier B.V. 2021-08 2021-07-18 /pmc/articles/PMC8286545/ /pubmed/34358943 http://dx.doi.org/10.1016/j.msard.2021.103155 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Giovannoni, Gavin Hawkes, Christopher H. Lechner-Scott, Jeannette Levy, Michael Yeh, E. Ann Baker, David COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title | COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title_full | COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title_fullStr | COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title_full_unstemmed | COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title_short | COVID-19 vaccines and multiple sclerosis disease-modifying therapies |
| title_sort | covid-19 vaccines and multiple sclerosis disease-modifying therapies |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286545/ https://www.ncbi.nlm.nih.gov/pubmed/34358943 http://dx.doi.org/10.1016/j.msard.2021.103155 |
| work_keys_str_mv | AT giovannonigavin covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies AT hawkeschristopherh covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies AT lechnerscottjeannette covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies AT levymichael covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies AT yeheann covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies AT bakerdavid covid19vaccinesandmultiplesclerosisdiseasemodifyingtherapies |